Ticker	Volume	Price	Price Delta
DJIA	15,354.40	+121.18	0.80%
S&P 500	1,667.47	+17.00	1.03%
Nasdaq	3,498.97	+33.72	0.97%

Ticker

Volume

Price

Price Delta

DJIA

15,354.40

+121.18

0.80%

S&P 500

1,667.47

+17.00

1.03%

Nasdaq

3,498.97

+33.72

0.97%

Ticker	Volume	Price	Price Delta
STOXX 50	2,817.99	+11.29	0.40%
FTSE 100	6,723.06	+35.26	0.53%
DAX	8,398.00	+28.13	0.34%

Ticker

Volume

Price

Price Delta

STOXX 50

2,817.99

+11.29

0.40%

FTSE 100

6,723.06

+35.26

0.53%

DAX

8,398.00

+28.13

0.34%

Ticker	Volume	Price	Price Delta
Nikkei	15,138.10	+100.88	0.67%
Hang Seng	23,082.70	+38.44	0.17%
S&P/ASX 200	5,180.77	+15.11	0.29%

Ticker

Volume

Price

Price Delta

Nikkei

15,138.10

+100.88

0.67%

Hang Seng

23,082.70

+38.44

0.17%

S&P/ASX 200

5,180.77

+15.11

0.29%

Exchange: Osaka
Sector: Consumer, Non-cyclical
Industry: Pharmaceuticals
Sub-Industry: Medical-Drugs

Biofermin Pharmaceutical Co Ltd

+ Add to Watchlist

4517:JP

2,808 JPY 10 0.36%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 02:10:06 ET on 05/17/2013.

Snapshot for Biofermin Pharmaceutical Co Ltd (4517)

Open:	2,805	Day's Range:	2,795 - 2,808	Volume:	2,000
Previous Close:	2,808	52wk Range:	1,578 - 2,860	1-Yr Rtn:	+82.83%

Stock Chart for 4517

No chart data available.

4517:JP 2,808

2,808

Interactive 4517 Chart

…

Previous Close

Key Statistics for 4517

Current P/E Ratio (ttm)	15.7748
Estimated P/E(-)	-
Relative P/E vs. TPX	0.6519
Earnings Per Share (ttm)	178.0050
Est. EPS	-
Est. PEG Ratio	-
Market Cap (M JPY)	34,128.43
Shares Outstanding (M)	12.15
30 Day Average Volume	3,830
Price/Book (mrq)	1.6582
Price/Sale (ttm)	3.2532
Dividend Indicated Gross Yield	2.14%
Cash Dividend (JPY)	30.0000
Last Dividend	09/26/2013
5 Year Dividend Growth	2.90%
Next Earnings Announcement	07/26/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4517

Revenue
Net Income (M/JPY)

Profit Margin (%)

Company Profile & Key Executives for 4517

BIOFERMIN PHARMACEUTICAL CO., LTD. manufactures pharmaceutical products and markets them through Takeda Chemical Industries in Japan and overseas markets. The Company sells its brand products, Biofermin, which is lactate gastrointestinal reagents. Biofermin also produces food stuffs, food additives, feed stuffs, and agrochemicals including fertilizer.